Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceutical research targeting kinase inhibitors. Its structure supports cross-coupling reactions, making it valuable in the development of novel therapeutic agents, especially in oncology drug discovery. The silyl protecting group enhances stability and selectivity during synthetic transformations, allowing for selective functionalization at later stages. Commonly employed in palladium-catalyzed reactions to construct complex heterocyclic systems found in drug candidates.